Research, Development, And Testing Services - Insider Trading Data
Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Research, industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.
Research, Development, And Testing Services - Insider Buy/Sell Ratio
Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.
We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).
Research, Development, And Testing Services - Transaction History
Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.
| Tran Date |
Security | Form | Insider | Code | Direct | Share Price |
Shares Changed |
|
|---|---|---|---|---|---|---|---|---|
| 2026-02-17 | NRC / NRC Health | 4 | HARRISON SHANE R IRA | I | 12.2703 | 8,000 | ||
| 2026-02-17 | MEDP / Medpace Holdings, Inc. | 4 | EWALD STEPHEN P | D | 138.87 | 3,500 | ||
| 2026-02-16 | OABI / OmniAb, Inc. | 4 | GUSTAFSON KURT A | D | 13,542 | |||
| 2026-02-16 | OABI / OmniAb, Inc. | 4 | Berkman Charles S | D | 13,542 | |||
| 2026-02-16 | OABI / OmniAb, Inc. | 4 | FOEHR MATTHEW W | D | 36,458 | |||
| 2026-02-13 | MEDP / Medpace Holdings, Inc. | 4 | BURWIG SUSAN E | D | 107.93 | 10,984 | ||
| 2026-02-13 | MEDP / Medpace Holdings, Inc. | 4 | Carley Brian T | D | 54.99 | 6,472 | ||
| 2026-02-13 | IQV / IQVIA Holdings Inc. | 4 | Haas Bernd | D | 166.94 | -20 | ||
| 2026-02-13 | IQV / IQVIA Holdings Inc. | 4 | Fedock Michael J. | D | 166.94 | -123 | ||
| 2026-02-12 | BUDZ / WEED, Inc. | 4 | BREEN NICOLE M Includes shares held by Nicole Breen and Ryan Breen (spouse) | I | 0.0325 | -35,000 | ||
| 2026-02-11 | BUDZ / WEED, Inc. | 4 | BREEN NICOLE M Includes shares held by Nicole Breen and Ryan Breen (spouse) | I | 0.0321 | -37,000 | ||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Cherofsky Keriann | D | 187.49 | -415 | ||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Fedock Michael J. | D | 187.49 | -2,420 | ||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | STAUB W RICHARD | D | 187.49 | -806 | ||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Haas Bernd | D | 187.49 | -440 | ||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | BOUSBIB ARI | D | 187.49 | -28,399 | ||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Sherbet Eric | D | 187.49 | -1,915 | ||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Grenfell Alistair | D | 187.49 | -5,545 | ||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Patel Bhavik | D | 187.49 | -1,920 | ||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Berkshire James G. | D | 187.49 | -1,280 | ||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Bruehlman Ronald E | D | 187.49 | -6,801 | ||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Bruehlman Ronald E | D | 16,335 | |||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Fedock Michael J. | D | 6,735 | |||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Haas Bernd | D | 8,265 | |||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Patel Bhavik | D | 4,083 | |||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | BOUSBIB ARI | D | 57,177 | |||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | STAUB W RICHARD | D | 2,722 | |||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Berkshire James G. | D | 2,722 | |||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Cherofsky Keriann | D | 1,087 | |||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Sherbet Eric | D | 6,806 | |||
| 2026-02-08 | IQV / IQVIA Holdings Inc. | 4 | Grenfell Alistair | D | 11,795 | |||
| 2026-02-07 | IQV / IQVIA Holdings Inc. | 4 | Fedock Michael J. | D | 187.49 | -111 | ||
| 2026-02-06 | ONMD / OneMedNet Corporation | 4 | Kosasa Thomas | D | 0.84 | 595,238 | ||
| 2026-02-04 | BUDZ / WEED, Inc. | 4 | BREEN NICOLE M Includes shares held by Nicole Breen and Ryan Breen (spouse) | I | 0.0355 | -58,980 | ||
| 2026-02-03 | BUDZ / WEED, Inc. | 4 | BREEN NICOLE M Includes shares held by Nicole Breen and Ryan Breen (spouse) | I | 0.0335 | -40,000 | ||
| 2026-02-03 | ABSI / Absci Corporation | 4 | Busch Andreas | D | 2.99 | -1,469 | ||
| 2026-02-02 | BUDZ / WEED, Inc. | 4 | BREEN NICOLE M Includes shares held by Nicole Breen and Ryan Breen (spouse) | I | 0.0350 | -31,625 | ||
| 2026-02-02 | ABSI / Absci Corporation | 4 | Jonasson Zachariah | D | 2.99 | -17,496 | ||
| 2026-02-02 | ABSI / Absci Corporation | 4 | McClain Sean | D | 2.99 | -26,761 | ||
| 2026-02-02 | NOTV / Inotiv, Inc. | 4 | Leasure Robert Jr. | D | 0.5034 | -113,297 | ||
| 2026-02-02 | ABSI / Absci Corporation | 4/A | McClain Sean | D | 2.99 | -26,761 | ||
| 2026-02-02 | INCY / Incyte Corporation | 4 | Morrissey Michael James | D | 102.67 | -185 | ||
| 2026-02-02 | INCY / Incyte Corporation | 4 | Heeson Lee | D | 102.67 | -111 | ||
| 2026-02-02 | ABSI / Absci Corporation | 4/A | Jonasson Zachariah | D | 2.99 | -17,496 | ||
| 2026-02-02 | ABSI / Absci Corporation | 4 | Bedrick Todd | D | 2.99 | -3,659 | ||
| 2026-01-30 | OABI / OmniAb, Inc. | 4 | HIGGINS JOHN L | D | 13,172 | |||
| 2026-01-30 | CRL / Charles River Laboratories International, Inc. | 4 | FOSTER JAMES C | D | 211.68 | -14,664 | ||
| 2026-01-30 | CRL / Charles River Laboratories International, Inc. | 4 | Knell Michael Gunnar | D | 211.68 | -526 | ||
| 2026-01-30 | CRL / Charles River Laboratories International, Inc. | 4 | Creamer Victoria L | D | 211.68 | -1,296 | ||
| 2026-01-30 | CRL / Charles River Laboratories International, Inc. | 4 | Mintz Mark | D | 211.68 | -655 |
